A prospective clinical study conducted at a tertiary care center in Southern India has demonstrated that the Peradeniya Organophosphorus Poisoning Scale, a six-parameter bedside assessment tool, matches the predictive accuracy of the more complex Acute Physiology, Age and Chronic Health Evaluation II score in identifying mortality risk among patients presenting with acute pesticide toxicity. The investigation, published in the International Journal of Emergency Medicine, followed adult patients admitted with confirmed acute organophosphorus ingestion to evaluate how effectively physiological scoring systems can predict major clinical complications, the requirement for invasive mechanical ventilation, and ultimate hospital mortality. Researchers found that while both tools exhibited robust performance across clinical endpoints, the simpler scale achieved statistical equivalence to the laboratory-intensive evaluation for fatal outcomes, offering critical utility for resource-constrained emergency environments.
Organophosphorus pesticide exposure represents one of the most pressing toxicological emergencies in developing nations, where occupational contact, unsafe chemical storage practices, and intentional self-poisoning drive substantial clinical caseloads. In agricultural regions across Asia, suicidal ingestion of agrochemicals imposes a formidable burden on primary and secondary health systems, with published estimates documenting mortality rates between 20 percent and 70 percent. Rural emergency departments frequently confront surging patient volumes while operating with limited staff, minimal diagnostic hardware, and restricted intensive care bed capacity. Although measurement of serum cholinesterase activity can confirm exposure to anticholinesterase compounds, testing remains costly, time-consuming, and broadly unavailable at peripheral health centers, while failing to provide reliable prognostic differentiation regarding the onset of acute respiratory failure or death.
To establish whether a rapid clinical scale could provide prognostic utility comparable to an established critical care scoring rubric, investigators evaluated consecutive admissions between December 2023 and May 2024. The prospective observational protocol recruited patients aged 18 years and older presenting with acute exposure verified by clinical history and characteristic features of cholinergic toxidrome, adhering to observational STROBE reporting guidelines. Out of 124 initial presentations, 24 individuals were excluded due to pre-existing sepsis, signs of atropinization prior to hospital evaluation, suspected co-ingestion of non-organophosphorus compounds, refusal of consent, or leaving against medical advice prior to required biological sampling. The final study cohort comprised 100 participants with an average age of 33.64 years, with individuals aged 40 years or younger accounting for 76 percent of the cohort and males representing 59 percent of enrolled patients.
The chemical profile of consumed compounds reflected common commercial agricultural agents, led by chlorpyrifos in 39 percent of patients, tribufos in 31 percent, diazinon in 16 percent, and malathion in 12 percent. Prominent clinical presentations included vomiting in 82 percent of cases, generalized muscle weakness in 31 percent, convulsions in 27 percent, and overt respiratory distress in 25 percent. Across the observed hospital stays, 15 percent of patients required endotracheal intubation and mechanical ventilation, and the overall in-hospital mortality reached 7 percent. Standardized management across all participants incorporated gastrointestinal decontamination, correction of metabolic disturbances, airway support, antimuscarinic therapy using atropine or glycopyrrolate, and oxime administration with pralidoxime to reverse acetylcholinesterase inhibition, with treatment decisions directed independently by attending clinical teams.
Physiological illness severity was quantified upon presentation using the Acute Physiology, Age and Chronic Health Evaluation II framework, which integrates age weighting, chronic health background, and an Acute Physiology Score assessing 12 parameters: core temperature, mean arterial pressure, heart rate, respiratory rate, oxygenation metrics, arterial pH, serum sodium, potassium, creatinine, hematocrit, total white blood cell count, and the Glasgow Coma Scale. Simultaneously, the treating clinicians calculated the Peradeniya Organophosphorus Poisoning Scale, a dedicated bedside system assessing six acute manifestations scored from zero to two: pupillary constriction, respiratory rate, cardiac pulse frequency, muscle fasciculations, conscious state, and active seizure manifestations. Total Peradeniya scores categorized patient severity into mild intoxication spanning 0 to 3 points, moderate intoxication covering 4 to 7 points, and severe toxicity indicated by scores from 8 to 11 points.
Analysis revealed profound statistical associations between elevated admission scores and adverse inpatient outcomes for both evaluation instruments. Patients who experienced severe complications demonstrated a mean APACHE II score of 13.4 compared to 4.12 among uncomplicated cases, while those requiring mechanical ventilation exhibited a mean of 14.8 compared to 6.06 in non-ventilated individuals. Non-survivors presented with an average APACHE II score of 18.71, in sharp contrast to a mean score of 6.52 among survivors. Stratification by Peradeniya severity categories showed complication rates escalating from 10.4 percent in mild cases to 80 percent in moderate cases and 100 percent in severe intoxication. Similarly, ventilatory support rose from 4.5 percent in the mild tier to 24 percent in moderate and 75 percent in severe classifications, with mortality reaching zero, 4 percent, and 75 percent across the respective strata.
Receiver operating characteristic curve calculations identified specific operational cutoffs optimizing sensitivity and specificity according to the Youden index. For the APACHE II score, an admission threshold of 7 or higher predicted inpatient complications with 94.3 percent sensitivity, 96.9 percent specificity, and an area under the curve of 0.99. A threshold of 9 or higher predicted mechanical ventilation requirement with 86.7 percent sensitivity, 82.4 percent specificity, and an area under the curve of 0.91, while a score of 16 or higher identified fatal outcomes with 85.7 percent sensitivity, 96.8 percent specificity, and an area under the curve of 0.98, with all associations demonstrating significance at p less than 0.01.
The bedside Peradeniya tool demonstrated parallel prognostic utility across equivalent endpoints. A score threshold of 3 or higher predicted clinical complications with 80 percent sensitivity, 92.3 percent specificity, and an area under the curve of 0.90, while the identical cutoff predicted mechanical ventilation needs with 80 percent sensitivity, 75.3 percent specificity, and an area under the curve of 0.85. For predicting hospital mortality, a Peradeniya score of 7 or higher yielded a sensitivity of 85.7 percent, a specificity of 97.8 percent, and an area under the curve of 0.99. Direct statistical evaluation between the two mortality receiver operating characteristic curves utilizing DeLong’s test revealed no significant difference between the Peradeniya scale and the APACHE II framework, yielding an area difference of 0.0175 with a 95 percent confidence interval spanning negative 0.0075 to 0.0425 and a p-value of 0.17.
These diagnostic findings expand upon prior toxicological investigations that independently validated physiological scoring methods but rarely performed direct comparative assessments within an identical prospective cohort. Prior literature had established that respiratory compromise represents the defining determinant of acute pesticide mortality, driven by severe bronchorrhea, bronchospasm, neuromuscular respiratory muscle weakness, central depression of the brainstem respiratory drive, and pulmonary aspiration. While the extensive APACHE II metric systematically captures arterial oxygenation and blood gas deviations, the clinical parameters within the Peradeniya framework effectively identify acute cholinergic respiratory crisis and neurological decline without requiring invasive blood gas sampling, immediate laboratory biochemistry, or prolonged calculation intervals.
Despite the high discriminatory capacity documented in the study, the investigators outlined notable limitations that temper immediate generalized implementation. The research was confined to a single tertiary academic center with a sample size of 100 individuals and recorded a modest absolute mortality count of seven events, precluding robust multivariable adjustment for underlying confounders. Furthermore, precise quantities of ingested pesticide compounds and the elapsed duration between chemical exposure and initial emergency presentation were unrecorded. The authors emphasize that while the rapid six-component Peradeniya scale provides a highly accessible bedside instrument for triaging sick patients and guiding aggressive intensive care referral, prospective multicenter investigations with larger cohorts remain necessary to validate these prognostic thresholds across varied clinical practice environments.
Subject of Research: Prognostic accuracy of clinical scoring systems in acute organophosphorus poisoning
Article Title: Comparison of Acute Physiology, Age and Chronic Health Evaluation II score and Peradeniya Organophosphorus Poisoning Scale in predicting clinical outcomes and mortality in organophosphorus poisoning
Article References: Thomas, G. G., Chandaka, S. K., Goud, S. R., Salim, S. P., Bangaru, P., & Kappagantu, V. (2026). Comparison of Acute Physiology, Age and Chronic Health Evaluation II score and Peradeniya Organophosphorus Poisoning Scale in predicting clinical outcomes and mortality in organophosphorus poisoning. International Journal of Emergency Medicine, 19(1), Article 266. https://doi.org/10.1186/s12245-026-01397-6
Image Credits: AI Generated
DOI: 10.1186/s12245-026-01397-6
Keywords: acute organophosphorus poisoning, APACHE II score, Peradeniya Organophosphorus Poisoning Scale, emergency medicine, critical care prognostication, pesticide toxicity, toxicological emergencies, cholinergic toxidrome, mechanical ventilation prediction, mortality risk stratification, DeLong test, intensive care triage, receiver operating characteristic, ventilator requirement, biochemical evaluation, tertiary care toxicology
News Source: Reid Dalton. (November 18, 2026). Simple Bedside Scale Matches Complex System in Predicting Organophosphate Poisoning Mortality. Scienmag.



